TNPO1
Basic information
Region (hg38): 5:72816312-72916733
Previous symbols: [ "KPNB2" ]
Links
Phenotypes
GenCC
Source:
- Tourette syndrome (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNPO1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 22 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 3 | |||||
Total | 0 | 0 | 22 | 9 | 2 |
Variants in TNPO1
This is a list of pathogenic ClinVar variants found in the TNPO1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-72816731-G-A | TNPO1-related disorder | Likely benign (May 28, 2019) | ||
5-72848388-A-T | not specified | Uncertain significance (Aug 20, 2023) | ||
5-72855848-G-A | not specified | Uncertain significance (May 29, 2024) | ||
5-72855931-A-G | TNPO1-related disorder | Benign (Jul 31, 2019) | ||
5-72861810-A-G | not specified | Uncertain significance (Mar 07, 2024) | ||
5-72861812-T-C | TNPO1-related disorder | Likely benign (Jul 11, 2019) | ||
5-72861900-T-A | not specified | Uncertain significance (Nov 29, 2023) | ||
5-72861900-T-C | not specified | Uncertain significance (Sep 13, 2023) | ||
5-72865610-C-T | TNPO1-related disorder | Likely benign (May 28, 2019) | ||
5-72865641-A-G | not specified | Uncertain significance (Jun 16, 2024) | ||
5-72865665-C-T | TNPO1-related disorder | Uncertain significance (Feb 03, 2023) | ||
5-72877257-T-G | not specified | Uncertain significance (Dec 16, 2022) | ||
5-72877271-T-C | not specified | Uncertain significance (Nov 07, 2023) | ||
5-72877324-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
5-72877342-C-T | TNPO1-related disorder | Benign (Nov 25, 2019) | ||
5-72883099-T-C | TNPO1-related disorder | Likely benign (Oct 17, 2019) | ||
5-72883119-G-A | not specified | Uncertain significance (Jan 20, 2023) | ||
5-72883177-A-C | not specified | Uncertain significance (Mar 01, 2023) | ||
5-72887090-C-G | not specified | Uncertain significance (Feb 22, 2023) | ||
5-72887168-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
5-72887228-CCTAAGTCCAGTTTGAATTATGTAAGTTGGCTTCTTACTACTATTAGGTACTAATAAGGCTAGGCTACTTTAAGG-C | Benign (Dec 31, 2019) | |||
5-72888068-T-G | TNPO1-related disorder | Likely benign (Mar 28, 2023) | ||
5-72888132-A-G | not specified | Uncertain significance (Jul 26, 2023) | ||
5-72888143-G-A | not specified | Uncertain significance (Jun 10, 2024) | ||
5-72888152-G-T | not specified | Uncertain significance (Dec 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TNPO1 | protein_coding | protein_coding | ENST00000337273 | 24 | 100422 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 3.74e-9 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.33 | 216 | 484 | 0.447 | 0.0000247 | 5978 |
Missense in Polyphen | 16 | 90.727 | 0.17635 | 1162 | ||
Synonymous | 0.333 | 162 | 167 | 0.967 | 0.00000864 | 1635 |
Loss of Function | 6.77 | 0 | 53.4 | 0.00 | 0.00000267 | 631 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates (PubMed:24753571). Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). Involved in nuclear import of M9- containing proteins. In vitro, binds directly to the M9 region of the heterogeneous nuclear ribonucleoproteins (hnRNP), A1 and A2 and mediates their nuclear import. Appears also to be involved in hnRNP A1/A2 nuclear export. Mediates the nuclear import of ribosomal proteins RPL23A, RPS7 and RPL5. Binds to a beta-like import receptor binding (BIB) domain of RPL23A. In vitro, mediates nuclear import of H2A, H2B, H3 and H4 histones, and SRP19 (By similarity). Mediates nuclear import of ADAR/ADAR1 isoform 1 and isoform 5 in a RanGTP-dependent manner (PubMed:19124606, PubMed:24753571). {ECO:0000250|UniProtKB:Q8BFY9, ECO:0000269|PubMed:11682607, ECO:0000269|PubMed:19124606, ECO:0000269|PubMed:24753571, ECO:0000269|PubMed:8986607, ECO:0000269|PubMed:9687515}.;
- Pathway
- Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Metabolism of RNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Intraflagellar transport;Cilium Assembly;Organelle biogenesis and maintenance
(Consensus)
Recessive Scores
- pRec
- 0.183
Intolerance Scores
- loftool
- 0.0473
- rvis_EVS
- -0.78
- rvis_percentile_EVS
- 12.77
Haploinsufficiency Scores
- pHI
- 0.971
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.694
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.928
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tnpo1
- Phenotype
Zebrafish Information Network
- Gene name
- tnpo1
- Affected structure
- slow muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- obsolete protein import into nucleus, translocation;NLS-bearing protein import into nucleus;ribosomal protein import into nucleus;viral process;intraciliary transport involved in cilium assembly;regulation of mRNA stability
- Cellular component
- nucleus;cytoplasm;cytosol;cilium;nuclear membrane;nuclear periphery;extracellular exosome
- Molecular function
- RNA binding;protein binding;nuclear localization sequence binding;Ran GTPase binding;protein transporter activity